Skip to main content

NSRX · Nasus Pharma Ltd · Short Volume

Track NSRX — free
$3.40 +0.08 (+2.41%)
Market Cap
$38.89M
Shares
11.71M
Volume · Oct 28 4064 Avg daily vol (3M) 17.84K

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Short Volume

Date Short Volume Short Exempt Total Volume Short %
2026-10-27 1,428 0 7,328 19.5%
2026-10-26 4,123 0 6,870 60.0%
2026-10-23 5,609 0 18,616 30.1%
2026-10-22 3,325 0 16,589 20.0%
2026-10-21 10,328 0 12,316 83.9%
2026-10-20 3,405 0 6,636 51.3%
2026-10-19 3,778 0 10,078 37.5%
2026-10-16 1,956 0 4,740 41.3%
2026-10-15 175 0 2,296 7.6%
2026-10-14 2,466 0 4,669 52.8%
2026-10-13 1,995 0 4,638 43.0%
2026-10-12 2,535 0 6,877 36.9%
2026-10-09 210 0 3,503 6.0%
2026-10-08 513 0 4,636 11.1%
2026-10-07 685 0 1,712 40.0%
2026-10-06 8,676 0 16,196 53.6%
2026-10-05 2,131 0 4,990 42.7%
2026-10-02 8,181 0 19,406 42.2%
2026-10-01 1,922 0 20,737 9.3%
2026-09-30 10,905 0 38,898 28.0%
2026-09-29 5,511 0 16,170 34.1%
2026-09-28 21,524 0 58,951 36.5%
2026-09-25 646 200 10,280 6.3%
2026-09-24 2,527 0 3,799 66.5%
2026-09-23 3,442 0 10,828 31.8%
2026-09-22 2,551 0 8,033 31.8%
2026-09-21 1,682 0 4,588 36.7%
2026-09-18 3,031 0 8,587 35.3%
2026-09-17 1,663 0 5,025 33.1%
2026-09-16 2,503 0 6,100 41.0%
2026-09-15 6,160 0 18,097 34.0%
2026-09-14 6,218 0 12,940 48.1%
2026-09-11 333 30 3,168 10.5%
2026-09-10 1,976 127 8,616 22.9%
2026-09-09 796 530 1,329 59.9%
2026-09-08 919 0 7,303 12.6%
2026-09-04 360 0 568 63.4%
2026-09-03 1,390 3 5,137 27.1%
2026-09-02 256 9 1,088 23.5%
2026-09-01 6,008 0 11,027 54.5%
2026-08-31 279 0 2,256 12.4%
2026-08-28 1,073 500 8,549 12.6%
2026-08-27 413 0 4,173 9.9%
2026-08-26 592 0 1,789 33.1%
2026-08-25 1,401 0 3,852 36.4%
2026-08-24 1,883 0 8,077 23.3%
2026-08-21 4,456 0 19,547 22.8%
2026-08-20 1,813 262 8,154 22.2%
2026-08-19 10,021 1,420 18,667 53.7%
2026-08-18 4,345 0 11,961 36.3%
Showing 1–50 of 65 days
Key facts CIK 2029039 CUSIP M7071P109 Visit website Investor relations